Download Understanding the Impact of Climate Change on Agriculture and more Lecture notes Pathology in PDF only on Docsity!
Upper Gastrointestinal Endoscopy
Policy Number: PG Last Review: 11/28/ GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder contract. Paramount applies coding edits to all medical claims through coding logic software to evaluate the accuracy and adherence to accepted national standards. This guideline is solely for explaining correct procedure reporting and does not imply coverage and reimbursement. SCOPE X Professional _ Facility DESCRIPTION Upper gastrointestinal (GI) endoscopy, or esophagogastroduodenoscopy (EGD) is usually performed to evaluate symptoms of persistent upper abdominal pain, nausea, vomiting, and difficulty swallowing or bleeding from the upper GI tract. EGD is more accurate than x-ray films for detecting inflammation, ulcers, or tumors of the esophagus, stomach and duodenum and can detect early cancer, as well as distinguish between benign and malignant conditions when biopsies of suspicious areas are obtained. Esophagogastroduodenoscopy (EGD) uses a flexible fiber-optic scope with a light and camera to examine the upper part of the GI system. The scope is inserted through the mouth into the upper GI tract allowing for direct visualization of the esophagus, stomach, and duodenum through the camera. This document does not address upper gastrointestinal (GI) endoscopy in children, wireless capsule endoscopy, virtual endoscopy or in vivo analysis of gastrointestinal lesions via endoscopy. POLICY
Upper gastrointestinal endoscopy does not require prior authorization.
Appropriate ICD-10 diagnosis code (as listed below) required for coverage. COVERAGE CRITERIA HMO, PPO, Individual Marketplace, Elite/ProMedica Medicare Plan, Advantage These procedures for adults aged 18 years or older can only be allowed if abnormal signs or symptoms or known disease are present.
- Indications which support EGD(s) for diagnostic purpose(s) are as follows: Upper abdominal distress which persists despite an appropriate trial of therapy; Upper abdominal distress associated with symptoms and/or signs suggesting serious organic disease (e.g., prolonged anorexia and weight loss); Dysphagia or odynophagia; Esophageal reflux symptoms which are persistent or recurrent despite appropriate therapy; Persistent vomiting of unknown cause; Other systemic diseases in which the presence of upper GI pathology might modify other planned management. Examples include patients with a history of GI bleeding who are scheduled for organ transplantation; long term anticoagulation; and chronic non-steroidal therapy for arthritis; X-ray findings of: o A suspected neoplastic lesion, for confirmation and specific histologic diagnosis; o Gastric or esophageal ulcer; or ADVANTAGE | ELITE | HMO INDIVIDUAL MARKETPLACE | PROMEDICA MEDICARE PLAN | PPO
o Evidence of upper gastrointestinal tract stricture or obstruction. The presence of gastrointestinal bleeding: o In most actively bleeding patients or those recently stopped; o When surgical therapy is contemplated; o When re-bleeding occurs after acute self-limited blood loss or after endoscopic therapy; o When portal hypertension or aorto-enteric fistula is suspected; or o For presumed chronic blood loss and for iron deficiency anemia when colonoscopy is negative. When sampling of duodenal or jejunal tissue or fluid is indicated; To assess acute injury after caustic agent ingestion; or Intraoperative EGD when necessary to clarify location or pathology of a lesion.
- Indications which support EGD(s) for therapeutic purpose(s) are as follows: Treatment of bleeding from lesions such as ulcers, tumors, vascular malformations (e.g., electrocoagulation, heater probe, laser photocoagulation or injection therapy); Sclerotherapy for bleeding from esophageal or proximal gastric varices or banding of varices; Foreign body removal; Removal of selected polypoid lesions; Placement of feeding tubes (oral, percutaneous endoscopic gastrostomy, percutaneous endoscopic jejunostomy); Dilation of stenotic lesions (e.g., with transendoscopic balloon dilators or dilating systems employing guidewires); or Palliative therapy of stenosing neoplasms (e.g., laser, bipolar electrocoagulation, stent placement).
- Sequential or periodic diagnostic upper GI endoscopy may be indicated for an appropriate number of procedures for active or symptomatic conditions. For follow-up of selected esophageal, gastric or stomal ulcers to demonstrate healing (frequency of follow- up EGDs is variable, but every two to four months until healing is demonstrated is reasonable); For follow-up in patients with prior adenomatous gastric polyps (approximate frequency of follow-up EGDs would be every one to four years depending on the clinical circumstances, with occasional patients with sessile polyps requiring every six-month surveillance initially); For follow-up for adequacy of prior sclerotherapy or banding of esophageal varices (approximate frequency of follow-up EGDs is very variable depending on the state of the patient but every six to twenty-four months is reasonable after the initial sclerotherapy/banding sessions are completed); For follow-up of Barrett's esophagus (approximate frequency of follow-up EGDs is one to two years with biopsies, unless dysplasia or atypia is demonstrated, in which case a repeat biopsy in two to three months might be indicated); or For follow-up in patients with familial adenomatous polyposis (approximate frequency of follow-up EGDs would be every two to four years, but might be more frequent, such as every six to twelve months if gastric adenomas or adenomas of the duodenum were demonstrated).
- The endoscopic retrograde cholangiopancreatography (ERCP) procedure is generally indicated for certain biliary and pancreatic conditions. ERCP is generally not indicated for the diagnosis of pancreatitis except for gallstone pancreatitis; ERCP is not usually indicated in early stages or in acute pancreatitis and could possibly exacerbate it; ERCP may be useful in traumatic pancreatitis to accurately localize the injury and provide endoscopic drainage; ERCP may be useful in pancreatic duct stricture evaluation; ERCP may be useful for the extraction of bile duct stones in severe gallstone induced pancreatitis; ERCP may be useful in detecting pancreatic ductal changes in chronic pancreatitis and also the presence of calcified stones in the ductal system. A pancreatogram may be performed and is likely to be abnormal in chronic alcoholic pancreatitis but less so in non-alcoholic induced types; ERCP may be useful in detecting gallstones in symptomatic patients whose oral cholecytogram and gallbladder ultrasonograms are normal; and ERCP may be indicated in patients with radiologic imaging suggestive of common bile duct stones or other potential pathology.
43215 Esophagoscopy, flexible, transoral; with removal of foreign body(s) 43216 Esophagoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps 43217 Esophagoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique 43220 Esophagoscopy, flexible, transoral; with transendoscopic balloon dilation (less than 30 mm diameter) 43226 Esophagoscopy, flexible, transoral; with insertion of guide wire followed by passage of dilator(s) over guide wire 43227 Esophagoscopy, flexible, transoral; with control of bleeding, any method 43229 Esophagoscopy, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed) 43231 Esophagoscopy, flexible, transoral; with endoscopic ultrasound examination 43232 Esophagoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s) 43233 Esophagogastroduodenoscopy, flexible, transoral; with dilation of esophagus with balloon (30 mm diameter or larger) (includes fluoroscopic guidance, when performed) 43235 Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed 43236 Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance 43237 Esophagogastroduodenoscopy, flexible, transoral; with endoscopic ultrasound examination limited to the esophagus, stomach or duodenum, and adjacent structures (^43238) Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine-needle aspiration/biopsy(s), (includes endoscopic ultrasound examination limited to the esophagus, stomach or duodenum, and adjacent structures) (^43239) Esophagogastroduodenoscopy, flexible, transoral; biopsy; single or multiple 43240 Esophagogastroduodenoscopy, with transmural drainage of pseudocyst (includes placement of transmural drainage catheter[s]/stent[s], when performed, and endoscopic ultrasound, when performed) 43241 Esophagogastroduodenoscopy, flexible, transoral; insertion of intraluminal tube or catheter 43242 Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided intramural or transmural fine-needle aspiration/biopsy(s) (includes endoscopic ultrasound examination of the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis) 43243 Esophagogastroduodenoscopy, flexible, transoral; injection sclerosis of esophageal/gastric varices 43244 Esophagogastroduodenoscopy, flexible, transoral; band ligation of esophageal/gastric varices 43245 Esophagogastroduodenoscopy, flexible, transoral; with dilation of gastric/duodenal stricture(s) (eg, balloon, bougie) 43246 Esophagogastroduodenoscopy, flexible, transoral; with directed placement of percutaneous gastrostomy tube 43247 Esophagogastroduodenoscopy, flexible, transoral; with removal of foreign body(s) 43248 Esophagogastroduodenoscopy, flexible, transoral; insertion of guide wire followed by passage of dilator(s) through esophagus over guide 43249 Esophagogastroduodenoscopy, flexible, transoral; transendoscopic balloon dilation of esophagus (<30mm) 43250 Esophagogastroduodenoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps 43251 Esophagogastroduodenoscopy, flexible, transoral; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique 43252 Esophagogastroduodenoscopy, flexible, transoral; with optical endomicroscopy 43253 Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic ultrasound-guided transmural injection of diagnostic or therapeutic substance(s) (eg, anesthetic, neurolytic agent) or fiducial marker(s) (includes endoscopic ultrasound examination of the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis)
43254 Esophagogastroduodenoscopy, flexible, transoral; with EMR (endoscopic mucosal resection) 43255 Esophagogastroduodenoscopy, flexible, transoral; with control of bleeding, any method 43257 Esophagogastroduodenoscopy, flexible, transoral; with delivery of thermal energy to the muscle of lower esophageal sphincter and/or gastric cardia, for treatment of gastroesophageal reflux disease 43259 Esophagogastroduodenoscopy, flexible, transoral; with endoscopic ultrasound examination, including the esophagus, stomach, and either the duodenum or a surgically altered stomach where the jejunum is examined distal to the anastomosis 43260 Endoscopic retrograde cholangiopancreatography (ERCP); diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure) 43261 Endoscopic retrograde cholangiopancreatography (ERCP); with biopsy, single or multiple 43262 Endoscopic retrograde cholangiopancreatography (ERCP); with sphincterotomy/papillotomy 43263 Endoscopic retrograde cholangiopancreatography (ERCP); with pressure measurement of sphincter of Oddi 43264 Endoscopic retrograde cholangiopancreatography (ERCP); with removal of calculi/debris from biliary/ pancreatic duct(s) 43265 Endoscopic retrograde cholangiopancreatography (ERCP); with destruction of calculi, any method (eg, mechanical, electrohydraulic, lithotripsy) 43266 Esophagogastroduodenoscopy, flexible, transoral; with placement of endoscopic stent (includes pre- and postdilation and guide wire passage, when performed) (^43270) Esophagogastroduodenoscopy, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed) 43274 Endoscopic retrograde cholangiopancreatography (ERCP); with placement of endoscopic stent into biliary or pancreatic duct, including pre- and postdilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent 43275 Endoscopic retrograde cholangiopancreatography (ERCP); with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) 43276 Endoscopic retrograde cholangiopancreatography (ERCP); with removal and exchange of stent(s), biliary or pancreatic duct, including pre- and postdilation and guide wire passage, when performed, including sphincterotomy, when performed, each stent exchanged 43277 Endoscopic retrograde cholangiopancreatography (ERCP); with trans-endoscopic balloon dilation of biliary/pancreatic duct(s) or of ampulla (sphincteroplasty), including sphincterotomy, when performed, each duct 43278 Endoscopic retrograde cholangiopancreatography (ERCP); with ablation of tumor(s), polyp(s), or other lesion(s), including pre- and post-dilation and guide wire passage, when performed ICD- 10 - CM CODES *Note: Codes Z46.51 and Z46.59 are allowed only for CPT codes 43275 and 43276 for the removal of a biliary stent. *Note: Diagnosis code E43 is allowed for CPT 43246 only. *Note: In addition to this list of ICD-10 codes, R93.2 is a covered diagnosis for CPT codes 43260, 43261, 43262, 43263, 43264, 43265, 43274, 43277, and 43278. B37.81 Candidal esophagitis C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant neoplasm of overlapping sites of esophagus C15.9 (^) Malignant neoplasm of esophagus, unspecified C16.0 Malignant neoplasm of cardia C16.1 Malignant neoplasm of fundus of stomach C16.2 Malignant neoplasm of body of stomach C16.3 Malignant neoplasm of pyloric antrum C16.4 Malignant neoplasm of pylorus C16.5 Malignant neoplasm of lesser curvature of stomach, unspecified C16.6 Malignant neoplasm of greater curvature of stomach, unspecified
K21.9 Gastro-esophageal reflux disease without esophagitis K22.0 Achalasia of cardia K22.10 Ulcer of esophagus without bleeding K22.11 Ulcer of esophagus with bleeding K22.2 Esophageal obstruction K22.3 Perforation of esophagus K22.4 Dyskinesia of esophagus K22.5 Diverticulum of esophagus, acquired K22.6 Gastro-esophageal laceration-hemorrhage syndrome K22.70 Barrett's esophagus without dysplasia K22.710 Barrett's esophagus with low grade dysplasia K22.711 Barrett's esophagus with high grade dysplasia K22.719 Barrett's esophagus with dysplasia, unspecified K22.8 (^) Other specified diseases of esophagus K25.0 Acute gastric ulcer with hemorrhage K25.1 Acute gastric ulcer with perforation K25.2 Acute gastric ulcer with both hemorrhage and perforation K25.3 Acute gastric ulcer without hemorrhage or perforation K25.4 Chronic or unspecified gastric ulcer with hemorrhage K25.5 (^) Chronic or unspecified gastric ulcer with perforation K25.6 Chronic or unspecified gastric ulcer with both hemorrhage and perforation K25.7 Chronic gastric ulcer without hemorrhage or perforation K25.9 (^) Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation K26.0 Acute duodenal ulcer with hemorrhage K26.1 Acute duodenal ulcer with perforation K26.2 Acute duodenal ulcer with both hemorrhage and perforation K26.3 Acute duodenal ulcer without hemorrhage or perforation K26.4 Chronic or unspecified duodenal ulcer with hemorrhage K26.5 Chronic or unspecified duodenal ulcer with perforation K26.6 Chronic or unspecified duodenal ulcer with both hemorrhage and perforation K26.7 Chronic duodenal ulcer without hemorrhage or perforation K26.9 Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation K27.0 Acute peptic ulcer, site unspecified, with hemorrhage K27.1 Acute peptic ulcer, site unspecified, with perforation K27.2 Acute peptic ulcer, site unspecified, with both hemorrhage and perforation K27.3 Acute peptic ulcer, site unspecified, without hemorrhage or perforation K27.4 (^) Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage K27.5 Chronic or unspecified peptic ulcer, site unspecified, with perforation K27.6 Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation K27.7 Chronic peptic ulcer, site unspecified, without hemorrhage or perforation K27.9 Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation K28.0 Acute gastrojejunal ulcer with hemorrhage K28.1 (^) Acute gastrojejunal ulcer with perforation K28.2 Acute gastrojejunal ulcer with both hemorrhage and perforation K28.3 Acute gastrojejunal ulcer without hemorrhage or perforation K28.4 Chronic or unspecified gastrojejunal ulcer with hemorrhage K28.5 Chronic or unspecified gastrojejunal ulcer with perforation K28.6 Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation K28.7 Chronic gastrojejunal ulcer without hemorrhage or perforation K28.9 Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation K29.00 Acute gastritis without bleeding K29.01 Acute gastritis with bleeding
K29.20 Alcoholic gastritis without bleeding K29.21 Alcoholic gastritis with bleeding K29.30 Chronic superficial gastritis without bleeding K29.31 Chronic superficial gastritis with bleeding K29.40 Chronic atrophic gastritis without bleeding K29.41 Chronic atrophic gastritis with bleeding K29.50 Unspecified chronic gastritis without bleeding K29.51 Unspecified chronic gastritis with bleeding K29.60 Other gastritis without bleeding K29.61 Other gastritis with bleeding K29.70 Gastritis, unspecified, without bleeding K29.71 Gastritis, unspecified, with bleeding K29.80 Duodenitis without bleeding K29.81 (^) Duodenitis with bleeding K29.90 Gastroduodenitis, unspecified, without bleeding K29.91 Gastroduodenitis, unspecified, with bleeding K31.1 Adult hypertrophic pyloric stenosis K31.2 Hourglass stricture and stenosis of stomach K31.3 Pylorospasm, not elsewhere classified K31.4 (^) Gastric diverticulum K31.5 Obstruction of duodenum K31.6 Fistula of stomach and duodenum K31.7 (^) Polyp of stomach and duodenum K31.811 Angiodysplasia of stomach and duodenum with bleeding K31.819 Angiodysplasia of stomach and duodenum without bleeding K31.82 Dieulafoy lesion (hemorrhagic) of stomach and duodenum K31.89 Other diseases of stomach and duodenum K44.0 Diaphragmatic hernia with obstruction, without gangrene K52.81 Eosinophilic gastritis or gastroenteritis K70.30 Alcoholic cirrhosis of liver without ascites K70.31 Alcoholic cirrhosis of liver with ascites K71.7 Toxic liver disease with fibrosis and cirrhosis of liver K74.3 Primary biliary cirrhosis K74.4 Secondary biliary cirrhosis K74.5 Biliary cirrhosis, unspecified K74.60 Unspecified cirrhosis of liver K74.69 (^) Other cirrhosis of liver K76.6 Portal hypertension K80.00 Calculus of gallbladder with acute cholecystitis without obstruction K80.01 Calculus of gallbladder with acute cholecystitis with obstruction K80.10 Calculus of gallbladder with chronic cholecystitis without obstruction K80.11 Calculus of gallbladder with chronic cholecystitis with obstruction K80.12 (^) Calculus of gallbladder with acute and chronic cholecystitis without obstruction K80.13 Calculus of gallbladder with acute and chronic cholecystitis with obstruction K80.18 Calculus of gallbladder with other cholecystitis without obstruction K80.19 Calculus of gallbladder with other cholecystitis with obstruction K80.20 Calculus of gallbladder without cholecystitis without obstruction K80.21 Calculus of gallbladder without cholecystitis with obstruction K80.30 Calculus of bile duct with cholangitis, unspecified, without obstruction K80.31 Calculus of bile duct with cholangitis, unspecified, with obstruction K80.32 Calculus of bile duct with acute cholangitis without obstruction K80.33 Calculus of bile duct with acute cholangitis with obstruction
K86.0 Alcohol-induced chronic pancreatitis K86.1 Other chronic pancreatitis K86.2 Cyst of pancreas K86.3 Pseudocyst of pancreas K86.81 Exocrine pancreatic insufficiency K86.89 Other specified diseases of pancreas K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere K91.30 Postprocedural intestinal obstruction, unspecified as to partial versus complete K91.31 Postprocedural partial intestinal obstruction K91.32 Postprocedural complete intestinal obstruction K91.5 Postcholecystectomy syndrome K91.81 Other intraoperative complications of digestive system K91.82 Postprocedural hepatic failure K91.83 (^) Postprocedural hepatorenal syndrome K91.86 Retained cholelithiasis following cholecystectomy K91.89 Other postprocedural complications and disorders of digestive system K92.0 Hematemesis K92.1 Melena K92.2 Gastrointestinal hemorrhage, unspecified K92.81 (^) Gastrointestinal mucositis (ulcerative) K94.23 Gastrostomy malfunction K94.30 Esophagostomy complications, unspecified K94.31 (^) Esophagostomy hemorrhage K94.32 Esophagostomy infection K94.33 Esophagostomy malfunction K94.39 Other complications of esophagostomy Q26.5 Anomalous portal venous connection Q26.6 Portal vein-hepatic artery fistula Q27.33 Arteriovenous malformation of digestive system vessel Q39.0 Atresia of esophagus without fistula Q39.1 Atresia of esophagus with tracheo-esophageal fistula Q39.2 Congenital tracheo-esophageal fistula without atresia Q39.3 Congenital stenosis and stricture of esophagus Q39.4 Esophageal web Q39.5 Congenital dilatation of esophagus Q39.6 Congenital diverticulum of esophagus Q39.8 (^) Other congenital malformations of esophagus Q39.9 Congenital malformation of esophagus, unspecified Q40.2 Other specified congenital malformations of stomach Q40.3 Congenital malformation of stomach, unspecified R07.9 Chest pain, unspecified R10.11 Right upper quadrant pain R10.12 (^) Left upper quadrant pain R10.13 Epigastric pain R10.33 Periumbilical pain R11.0 Nausea R11.10 Vomiting, unspecified R11.11 Vomiting without nausea R11.12 Projectile vomiting R11.2 Nausea with vomiting, unspecified R12 Heartburn R13.0 Aphagia
R13.10 Dysphagia, unspecified R13.11 Dysphagia, oral phase R13.12 Dysphagia, oropharyngeal phase R13.13 Dysphagia, pharyngeal phase R13.14 Dysphagia, pharyngoesophageal phase R13.19 Other dysphagia R17 Unspecified jaundice R22.2 Localized swelling, mass and lump, trunk R59.0 Localized enlarged lymph nodes R59.1 Generalized enlarged lymph nodes R59.9 Enlarged lymph nodes, unspecified R63.0 Anorexia R63.3 Feeding difficulties R63.4 (^) Abnormal weight loss R68.89 Other general symptoms and signs R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract S11.20XA Unspecified open wound of pharynx and cervical esophagus, initial encounter S11.20XD Unspecified open wound of pharynx and cervical esophagus, subsequent encounter S11.20XS Unspecified open wound of pharynx and cervical esophagus, sequela S11.21XA (^) Laceration without foreign body of pharynx and cervical esophagus, initial encounter S11.21XD Laceration without foreign body of pharynx and cervical esophagus, subsequent encounter S11.21XS Laceration without foreign body of pharynx and cervical esophagus, sequela S11.23XA (^) Puncture wound without foreign body of pharynx and cervical esophagus, initial encounter S11.23XD Puncture wound without foreign body of pharynx and cervical esophagus, subsequent encounter S11.23XS Puncture wound without foreign body of pharynx and cervical esophagus, sequela S11.25XA Open bite of pharynx and cervical esophagus, initial encounter S11.25XD Open bite of pharynx and cervical esophagus, subsequent encounter S11.25XS Open bite of pharynx and cervical esophagus, sequela S21.309A Unspecified open wound of unspecified front wall of thorax with penetration into thoracic cavity, initial encounter S21.309D Unspecified open wound of unspecified front wall of thorax with penetration into thoracic cavity, subsequent encounter S21.309S Unspecified open wound of unspecified front wall of thorax with penetration into thoracic cavity, sequela S27.812A Contusion of esophagus (thoracic part), initial encounter S27.812D Contusion of esophagus (thoracic part), subsequent encounter S27.812S (^) Contusion of esophagus (thoracic part), sequela S27.813A Laceration of esophagus (thoracic part), initial encounter S27.813D Laceration of esophagus (thoracic part), subsequent encounter S27.813S Laceration of esophagus (thoracic part), sequela S27.818A Other injury of esophagus (thoracic part), initial encounter S27.818D Other injury of esophagus (thoracic part), subsequent encounter S27.818S (^) Other injury of esophagus (thoracic part), sequela S27.819A Unspecified injury of esophagus (thoracic part), initial encounter S27.819D Unspecified injury of esophagus (thoracic part), subsequent encounter S27.819S Unspecified injury of esophagus (thoracic part), sequela T18.100A Unspecified foreign body in esophagus causing compression of trachea, initial encounter T18.100D Unspecified foreign body in esophagus causing compression of trachea, subsequent encounter T18.100S Unspecified foreign body in esophagus causing compression of trachea, sequela T18.108A Unspecified foreign body in esophagus causing other injury, initial encounter T18.108D Unspecified foreign body in esophagus causing other injury, subsequent encounter T18.108S Unspecified foreign body in esophagus causing other injury, sequela
T54.1X3D Toxic effect of other corrosive organic compounds, assault, subsequent encounter T54.1X3S Toxic effect of other corrosive organic compounds, assault, sequela T54.1X4A Toxic effect of other corrosive organic compounds, undetermined, initial encounter T54.1X4D Toxic effect of other corrosive organic compounds, undetermined, subsequent encounter T54.1X4S Toxic effect of other corrosive organic compounds, undetermined, sequela T54.3X1A Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), initial encounter T54.3X1D Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), subsequent encounter T54.3X1S Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), sequela T54.3X2A Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, initial encounter T54.3X2D Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, subsequent encounter T54.3X2S Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, sequela T54.3X3A Toxic effect of corrosive alkalis and alkali-like substances, assault, initial encounter T54.3X3D Toxic effect of corrosive alkalis and alkali-like substances, assault, subsequent encounter T54.3X3S Toxic effect of corrosive alkalis and alkali-like substances, assault, sequela T54.3X4A Toxic effect of corrosive alkalis and alkali-like substances, undetermined, initial encounter T54.3X4D Toxic effect of corrosive alkalis and alkali-like substances, undetermined, subsequent encounter T54.3X4S Toxic effect of corrosive alkalis and alkali-like substances, undetermined, sequela T54.91XA (^) Toxic effect of unspecified corrosive substance, accidental (unintentional), initial encounter T54.91XD Toxic effect of unspecified corrosive substance, accidental (unintentional), subsequent encounter T54.91XS Toxic effect of unspecified corrosive substance, accidental (unintentional), sequela T54.92XA Toxic effect of unspecified corrosive substance, intentional self-harm, initial encounter T54.92XD Toxic effect of unspecified corrosive substance, intentional self-harm, subsequent encounter T54.92XS Toxic effect of unspecified corrosive substance, intentional self-harm, sequela T54.93XA (^) Toxic effect of unspecified corrosive substance, assault, initial encounter T54.93XD Toxic effect of unspecified corrosive substance, assault, subsequent encounter T54.93XS Toxic effect of unspecified corrosive substance, assault, sequela T54.94XA Toxic effect of unspecified corrosive substance, undetermined, initial encounter T54.94XD Toxic effect of unspecified corrosive substance, undetermined, subsequent encounter T54.94XS Toxic effect of unspecified corrosive substance, undetermined, sequela T57.1X1A Toxic effect of phosphorus and its compounds, accidental (unintentional), initial encounter T57.1X1D Toxic effect of phosphorus and its compounds, accidental (unintentional), subsequent encounter T57.1X1S Toxic effect of phosphorus and its compounds, accidental (unintentional), sequela T57.1X2A Toxic effect of phosphorus and its compounds, intentional self-harm, initial encounter T57.1X2D Toxic effect of phosphorus and its compounds, intentional self-harm, subsequent encounter T57.1X2S Toxic effect of phosphorus and its compounds, intentional self-harm, sequela T57.1X3A Toxic effect of phosphorus and its compounds, assault, initial encounter T57.1X3D Toxic effect of phosphorus and its compounds, assault, subsequent encounter T57.1X3S (^) Toxic effect of phosphorus and its compounds, assault, sequela T57.1X4A Toxic effect of phosphorus and its compounds, undetermined, initial encounter T57.1X4D Toxic effect of phosphorus and its compounds, undetermined, subsequent encounter T57.1X4S (^) Toxic effect of phosphorus and its compounds, undetermined, sequela Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm Z Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm Z46.51* Encounter for fitting and adjustment of gastric lap band Z46.59* Encounter for fitting and adjustment of other gastrointestinal appliance and device Z79.01 Long term (current) use of anticoagulants Z79.3 Long term (current) use of hormonal contraceptives Z79.51 Long term (current) use of inhaled steroids Z79.52 Long term (current) use of systemic steroids
Z79.82 Long term (current) use of aspirin Z79.891 Long term (current) use of opiate analgesic Z79.899 Other long term (current) drug therapy Z85.00 Personal history of malignant neoplasm of unspecified digestive organ Z85.01 Personal history of malignant neoplasm of esophagus Z85.028 Personal history of other malignant neoplasm of stomach REVISION HISTORY EXPLANATION ORIGINAL EFFECTIVE DATE: 11/28/ 11/28/ 2018 : Upper gastrointestinal endoscopy does not require prior authorization. Appropriate ICD- 10 diagnosis code (as listed above) required for coverage. 12/09/2020: Medical policy placed on the new Paramount Medical Policy Format. REFERENCES/RESOURCES Centers for Medicare and Medicaid Services, CMS Manual System and other CMS publications and services Ohio Department of Medicaid American Medical Association, Current Procedural Terminology (CPT®) and associated publications and services Centers for Medicare and Medicaid Services, Healthcare Common Procedure Coding System, HCPCS Release and Code Sets Industry Standard Review Hayes, Inc.
